The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome

Cardiology Journal

Volumn 18, Issue 5, 2011, Pages 496-502

  Bozkurt, Sebnem ^a   Kaya, Ergun Baris ^a   Okutucu, Sercan ^a   Aytemir, Kudret ^a   Coskun, Figen ^a   Oto, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Chest pain; Diagnosis; Glycogen phosphorylase; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN PHOSPHORYLASE ISOENZYME BB; MYOGLOBIN; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; ELECTROCARDIOGRAM; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; FIRST HOUR OF HOSPITAL ADMISSION; GENDER; GLOMERULUS FILTRATION RATE; GOLD STANDARD; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONCARDIAC CHEST PAIN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME; TREADMILL EXERCISE; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CREATINE KINASE, MB FORM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOGEN PHOSPHORYLASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGLOBIN; PATIENT ADMISSION; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN T; TURKEY;

EID: 80053023017     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: 10.5603/CJ.2011.0004     Document Type: Article

References (17)

1. Pollack CV, Jr., Antman EM, Hollander JE. 2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: Implications for emergency department practice. Ann Emerg Med, 2008; 52: 344-355e1.
2. Van de Werf F, Bax J, Betriu A et al. ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Rev Esp Cardiol, 2009; 62: 293.
3. Pollack CV, Jr., Braunwald E. 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Implications for emergency department practice. Ann Emerg Med, 2008; 51: 591-606.
4. Rabitzsch G, Kossler A, Krause EG. Immunoinhibition test for human glycogen phosphorylase BB in the diagnosis of acute myocardial infarct. Z Med Lab Diagn, 1989; 30: 25-27.
5. Rabitzsch G, Mair J, Lechleitner P et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem, 1995; 41: 966-978.
6. Apple FS. Glycogen phosphorylase BB and other cardiac proteins: Challenges to creatine kinase MB as the marker for detecting myocardial injury. Clin Chem, 1995; 41: 963-965.
7. Garrett J, Knight E, Fawzy EM, Pridie RB, Raftery EB, Towers MK. Proceedings: Coronary angiography using Judkins method. Br Heart J, 1974; 36: 399.
8. Bigi R, Cortigiani L, Colombo P, Desideri A, Bax JJ, Parodi O. Prognostic and clinical correlates of angiographically diffuse non--obstructive coronary lesions. Heart, 2003; 89: 1009-1013.
9. Diagenics. Diacordon Glycogen Phosphorylase Isoenzyme BB-ELISA. Enzyme-linked immunosorbent assay for quantitative detection of GP-BB in human plasma or serum. Product Information and Instruction Manual 2004, June: 3-9.
10. Myers GL, Miller WG, Coresh J et al. Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem, 2006; 52: 5-18.
11. Peetz D, Post F, Schinzel H et al. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med, 2005; 43: 1351-1358.
12. Hofmann U, Rabitzsch G, Loster K, Handschack W, Noll F, Krause EG. Immunenzymometric assay for the heart specific glycogen phosphorylase BB in human serum using monoclonal antibodies. Biomed Biochim Acta, 1989; 48: S132-S136.
13. Lacnak B, Stejskal D, Jedelsky L, Karpisek M, Sprongl L. Utilization of glycogen phosphorylase BB measurement in the diagnosis of acute coronary syndromes in the event of chest pain. Vnitr Lek, 2007; 53: 1164-1169.
14. Stejskal D, Lacnak B, Jedelsky L et al. Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2007; 151: 247-249.
15. Mair J, Puschendorf B, Smidt J et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. Br Heart J, 1994; 72: 125-127.
16. Krause EG, Rabitzsch G, Noll F, Mair J, Puschendorf B. Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction. Mol Cell Biochem, 1996; 160-161: 289-295.
17. Rabitzsch G, Mair J, Lechleitner P et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet, 1993; 341: 1032-1033.